Jose M. Trevejo - Feb 1, 2022 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role: CHIEF MEDICAL OFFICER
Signature: /s/ Leonard M. Greenstein
Stock symbol: TARS
Transactions as of: Feb 1, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/3/2022, 04:36 PM
Next filing: Mar 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TARS	Employee Stock Option (right to buy)	Award	$0	+116K		$0.00	116K	Feb 1, 2022	Common Stock	116K	$20.64	Direct	F1
transaction	TARS	Restricted Stock Units	Award	$0	+30.2K		$0.00	30.2K	Feb 1, 2022	Common Stock	30.2K		Direct	F2, F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the option shares shall vest on February 1, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service.
F2	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
F3	25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service.